尿道癌-话题@MedSci

#尿道癌#

9篇内容 | 1298人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1379585, encodeId=dda913e958540, content=<a href='/topic/show?id=755b4e5461b' target=_blank style='color:#2F92EE;'>#尿道癌#</a>, objectTitle=Eur Urol Oncol：高危上尿路尿道癌根治术后的肿瘤学监测, objectType=article, longId=727390, objectId=19e3e2739016, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=19e3e2739016, replyNumber=0, likeNumber=81, createdTime=2022-05-21, rootId=0, userName=neurosurgeon, userId=a119458, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=19e3e2739016, moduleTitle=Eur Urol Oncol：高危上尿路尿道癌根治术后的肿瘤学监测, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=19e3e2739016)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1379584, encodeId=9a6113e958446, content=<a href='/topic/show?id=755b4e5461b' target=_blank style='color:#2F92EE;'>#尿道癌#</a>, objectTitle=BJU Int：组织学变异对pembrolizumab治疗的尿道癌患者结果的影响, objectType=article, longId=213553, objectId=fca92135533b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fca92135533b, replyNumber=0, likeNumber=83, createdTime=2021-07-02, rootId=0, userName=neurosurgeon, userId=a119458, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fca92135533b, moduleTitle=BJU Int：组织学变异对pembrolizumab治疗的尿道癌患者结果的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fca92135533b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1379583, encodeId=403513e95830e, content=<a href='/topic/show?id=755b4e5461b' target=_blank style='color:#2F92EE;'>#尿道癌#</a>, objectTitle=J Urol：根治性膀胱癌切除术后复发尿道癌的风险因素及预后, objectType=article, longId=211951, objectId=d4f32119518e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d4f32119518e, replyNumber=0, likeNumber=87, createdTime=2021-05-29, rootId=0, userName=neurosurgeon, userId=a119458, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d4f32119518e, moduleTitle=J Urol：根治性膀胱癌切除术后复发尿道癌的风险因素及预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d4f32119518e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1379582, encodeId=a12213e95826a, content=<a href='/topic/show?id=755b4e5461b' target=_blank style='color:#2F92EE;'>#尿道癌#</a>, objectTitle=Nat Commun：炎症性癌症相关成纤维细胞在膀胱尿道癌中的作用, objectType=article, longId=202266, objectId=d233202266e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d233202266e0, replyNumber=0, likeNumber=74, createdTime=2020-10-20, rootId=0, userName=neurosurgeon, userId=a119458, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d233202266e0, moduleTitle=Nat Commun：炎症性癌症相关成纤维细胞在膀胱尿道癌中的作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d233202266e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1379581, encodeId=cbb113e9581cc, content=<a href='/topic/show?id=755b4e5461b' target=_blank style='color:#2F92EE;'>#尿道癌#</a>, objectTitle=Eur Urol：局部晚期和转移性尿道癌中成纤维细胞生长因子受体3的变异状态与对铂化疗敏感性的差异相关, objectType=article, longId=199985, objectId=72b119998516, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=72b119998516, replyNumber=0, likeNumber=72, createdTime=2020-08-29, rootId=0, userName=neurosurgeon, userId=a119458, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=72b119998516, moduleTitle=Eur Urol：局部晚期和转移性尿道癌中成纤维细胞生长因子受体3的变异状态与对铂化疗敏感性的差异相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=72b119998516)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1379580, encodeId=cb5613e958072, content=<a href='/topic/show?id=755b4e5461b' target=_blank style='color:#2F92EE;'>#尿道癌#</a>, objectTitle=Int J Clin Oncol：PembrolizumabVS化疗治疗复发性晚期尿道癌的疗效, objectType=article, longId=198492, objectId=2b63198492b1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b63198492b1, replyNumber=0, likeNumber=69, createdTime=2020-08-02, rootId=0, userName=neurosurgeon, userId=a119458, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b63198492b1, moduleTitle=Int J Clin Oncol：PembrolizumabVS化疗治疗复发性晚期尿道癌的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2b63198492b1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1379579, encodeId=21c613e957919, content=<a href='/topic/show?id=755b4e5461b' target=_blank style='color:#2F92EE;'>#尿道癌#</a>, objectTitle=第34届欧洲泌尿外科学会（EAU）大会：Atezolizumab对晚期转移性泌尿道癌有效, objectType=article, longId=162734, objectId=ed6f162e344b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ed6f162e344b, replyNumber=0, likeNumber=84, createdTime=2019-03-23, rootId=0, userName=neurosurgeon, userId=a119458, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ed6f162e344b, moduleTitle=第34届欧洲泌尿外科学会（EAU）大会：Atezolizumab对晚期转移性泌尿道癌有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ed6f162e344b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1379578, encodeId=cc9a13e9578c0, content=<a href='/topic/show?id=755b4e5461b' target=_blank style='color:#2F92EE;'>#尿道癌#</a>, objectTitle=Ann Oncol：当代化疗模式对晚期泌尿道癌患者生存期的影响：浸润性尿路上皮癌（RISC）的回顾性国际研究。, objectType=article, longId=118987, objectId=f6e211898e5f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f6e211898e5f, replyNumber=0, likeNumber=70, createdTime=2017-11-08, rootId=0, userName=neurosurgeon, userId=a119458, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f6e211898e5f, moduleTitle=Ann Oncol：当代化疗模式对晚期泌尿道癌患者生存期的影响：浸润性尿路上皮癌（RISC）的回顾性国际研究。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f6e211898e5f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1379577, encodeId=c6f313e95777f, content=<a href='/topic/show?id=755b4e5461b' target=_blank style='color:#2F92EE;'>#尿道癌#</a>, objectTitle=根治性膀胱切除术后发生尿道癌的危险因素分析, objectType=article, longId=86086, objectId=af0886086bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af0886086bc, replyNumber=0, likeNumber=67, createdTime=2016-12-31, rootId=0, userName=neurosurgeon, userId=a119458, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af0886086bc, moduleTitle=根治性膀胱切除术后发生尿道癌的危险因素分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af0886086bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

尿道癌

2020-05-29

neurosurgeon (审核中...)

前往app查看评论内容

#尿道癌#

Eur Urol Oncol：高危上尿路尿道癌根治术后的肿瘤学监测

2022-05-21

neurosurgeon (审核中...)

前往app查看评论内容

#尿道癌#

BJU Int：组织学变异对pembrolizumab治疗的尿道癌患者结果的影响

2021-07-02

neurosurgeon (审核中...)

前往app查看评论内容

#尿道癌#

J Urol：根治性膀胱癌切除术后复发尿道癌的风险因素及预后

2021-05-29

neurosurgeon (审核中...)

前往app查看评论内容

#尿道癌#

Nat Commun：炎症性癌症相关成纤维细胞在膀胱尿道癌中的作用

2020-10-20

neurosurgeon (审核中...)

前往app查看评论内容

#尿道癌#

Eur Urol：局部晚期和转移性尿道癌中成纤维细胞生长因子受体3的变异状态与对铂化疗敏感性的差异相关

2020-08-29

neurosurgeon (审核中...)

前往app查看评论内容

#尿道癌#

Int J Clin Oncol：PembrolizumabVS化疗治疗复发性晚期尿道癌的疗效

2020-08-02

neurosurgeon (审核中...)

前往app查看评论内容

#尿道癌#

第34届欧洲泌尿外科学会（EAU）大会：Atezolizumab对晚期转移性泌尿道癌有效

2019-03-23

neurosurgeon (审核中...)

前往app查看评论内容

#尿道癌#

Ann Oncol：当代化疗模式对晚期泌尿道癌患者生存期的影响：浸润性尿路上皮癌（RISC）的回顾性国际研究。

2017-11-08

neurosurgeon (审核中...)

前往app查看评论内容

#尿道癌#

根治性膀胱切除术后发生尿道癌的危险因素分析

2016-12-31

科室
- - 订阅+
  - 更多科室
工具
服务